2023 annual financial data
Enveric Biosciences 2023 Operating cash flow growth
Direct answer
Operating cash flow growth was 17.8%.
Operating income was -16,448,440 USD and net income was -17,291.73 USD.
Operating cash flow was -14,094,411 USD.
Get free Enveric Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -16,448,440 USD
- Net income
- -17,291.73 USD
- Operating cash flow
- -14,094,411 USD